Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challengesArch Pharm Res2022.12.03
Development of JAK inhibitors for the treatment of immune-mediated diseases: kinase-targeted inhibitors and pseudokinase-targeted inhibitorsARCHIVES OF PHARMACAL RESEARCH2020.11.08
Development of BTK inhibitors for the treatment of B-cell malignanciesARCHIVES OF PHARMACAL RESEARCH2019.01.31
연구과제
주식회사 케이피티신규 표적항암제 임상 개발2023.06.13 ~ 2024.06.12
건양대학교글로벌 지형에서의 신약개발전략 변화에 대한 연구2023.05.01 ~ 2024.04.30
주식회사 빅씽크프로젝트 포트폴리오 관리(Project portfolio management)2020.12.15 ~ 2021.12.14
건양대학교Development of JAK inhibitors for the treatment of immune-mediated diseases: kinase-targeted inhibitors and pseudokinase-targeted inhibitors2019.07.01 ~ 2020.06.30
LSK Biopartners, Inc.프로젝트 포트폴리오 관리 (Project portfolio management)2017.12.20 ~ 2019.12.19
LSK Biopartners, Inc.항암제분야 비즈니스 인텔리전스 개발2015.12.07 ~ 2016.12.06
LSK Biopartners, Inc.Apatinib의 신규 표적항암제로서의 가치분석2014.12.29 ~ 2015.03.31